Anthony E. Choudhry

Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity

Charity Atkins, Qi Liu, Elisabeth A. Minthorn et al. · Cancer Research · 2013 · 426 citations

Tumor Biology, Signaling Pathway, Upr Signaling +21

Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity

Nelson Rhodes, Dirk A. Heerding, Derek R. Duckett et al. · Cancer Research · 2008 · 296 citations · Full text

Tumor Xenografts, Antitumor Activity, Chemoprevention Strategy +21

Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3<i>S</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase

Dirk A. Heerding, Nelson Rhodes, Jack D. Leber et al. · Journal of Medicinal Chemistry · 2008 · 154 citations · Full text

Cell Death, Akt Kinase, Molecular Pharmacology +20

Biochemical Characterization of the Interactions of the Novel Pleuromutilin Derivative Retapamulin with Bacterial Ribosomes

Kang Yan, Lenore Madden, Anthony E. Choudhry et al. · Antimicrobial Agents and Chemotherapy · 2006 · 118 citations · Full text

Crystal structure and substrate specificity of the β‐ketoacyl‐acyl carrier protein synthase III (FabH) from <i>Staphylococcus aureus</i>

Xiayang Qiu, Anthony E. Choudhry, Cheryl A. Janson et al. · Protein Science · 2005 · 99 citations · Full text